ESTHER WAITHAKA: Open Payments
NPI 1356796627 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 37 payments from 15 companies in 2025. Trend: 2023 $190 · 2024 $649 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| TOLMAR, INC. | 7 | $117 |
| Almatica Pharma LLC | 4 | $99 |
| Astellas Pharma US Inc | 5 | $92 |
| ABBVIE INC. | 4 | $69 |
| Indivior Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Braeburn Inc. | 2 | $46 |
| Azurity Pharmaceuticals, Inc. | 2 | $44 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $29 |
| OptumHealth Care Solutions, LLC | 1 | $23 |
Products named: JATENZO, LOREEV XR, Veozah, SUBLOCADE, VRAYLAR, CAPLYTA, BRIXADI, AZMIRO.
Industry payments across TX — which companies pay providers there.
